Both in Biotechnology
Vaxcyte vs Neurocrine Biosciences
Over the past year PCVX returned +37.0% and NBIX returned +2.0%; their daily moves had a correlation of 0.23.
PCVX +37.0% NBIX +2.0%Growth of $1, one year, split-adjusted
| Metric | PCVX | NBIX |
|---|---|---|
| Price | $62.03 | $146.10 |
| Market cap | $9.76B | $14.85B |
| Today | −0.93% | −0.19% |
| 1 month | +10.7% | +3.8% |
| 6 months | +9.0% | +10.9% |
| Year to date | +34.4% | +3.0% |
| 1 year | +42.5% | +5.9% |
| Revenue growth (YoY) | — | +39.5% |
| Gross margin | — | 97.6% |
| Net margin | — | 15.1% |
| P/E (TTM) | — | 21.1× |
| Price / sales | — | 4.4× |
| Net cash | $1.49B | $389.8M |
| Dividend yield | — | — |
| Volatility (60d) | 70.5% | 26.3% |
| Short % of float | 11.2% | 6.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).